Company / Interest Expense
Ensysce Biosciences, Inc. Interest Expense History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$8.8K
FY2025
5-year range
$8.8K / $1.3M
FY2022-FY2025
Trend
-39.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has declined for 3 consecutive years, from $1M in FY2022 to $8,848 in FY2025.
Based on SEC 10-K filings.
$8,848 in FY2025 with a 3-year CAGR of -81.0%.
Improved from $109,525 to $8,848 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -81.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Ensysce Biosciences, Inc.'s interest expense has declined for 3 consecutive years.
- 3-year CAGR of -81.0%, indicating a declining trend.
- In FY2025, interest expense decreased 39.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.8K | -39.9% |
| FY2024 | $14.7K | -86.6% |
| FY2023 | $109.5K | -91.5% |
| FY2022 | $1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026